Vivoryon Therapeutics
Drug development for the treatment of Alzheimer’s disease
![Vivoryon Logo RGB Vivoryon Logo](https://www.bmp.com/wp-content/uploads/2022/05/vivoryon-logo-rgb.svg 1x, https://www.bmp.com/wp-content/uploads/2022/05/vivoryon-logo-rgb.svg 2x)
About Vivoryon Therapeutics
Targeting diseases at their molecular root
Vivoryon Therapeutics is a biopharmaceutical company engaged in the research and development of novel therapeutic products, primarily for the treatment of Alzheimer’s disease. Vivoryon has identified a novel therapeutic concept related to disease initiation and progression. The development approach focusses on pyroglutamate-Abeta (pGlu-Abeta) as a therapeutic strategy to target Alzheimer’s disease.
Management
bmp Ventures Team
Founded
1997
Invested
1997
Stage
Expansion
Industry
Life Sciences & eHealth
Status
Aktiv